drugset / Trial / NCT06959511
Zanzalintinib for the Treatment of Advanced Thyroid Cancer Before Surgery
NaSingle-groupOpen-labelTreatment
Summary
To look at the effectiveness of zanzalintinib, followed by surgery, in treating advanced thyroid cancer. The safety of this treatment will also be studied.
Timeline
- Start
- 2025-07-22
- Primary completion
- 2028-03-01
- Completion
- 2030-10-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Zanzalintinib | Small molecule | 60 mg | Oral |